Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients

被引:12
|
作者
Jiang, YongWei [1 ]
Ma, Liang [2 ,3 ]
Han, ChengWu [1 ]
Liu, Qian [1 ]
Cong, Xiao [1 ]
Xu, YaPing [4 ]
Zhao, TingTing [3 ]
Li, Ping [2 ,3 ]
Cao, YongTong [1 ]
机构
[1] China Japan Friendship Hosp, Clin Lab, Beijing, Peoples R China
[2] Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China
[4] China Japan Friendship Hosp, Inst Clin Med Sci, Dept Pathophysiol, Beijing, Peoples R China
关键词
E GENE POLYMORPHISM; RENAL-DISEASE; APOE POLYMORPHISM; KIDNEY-DISEASE; ASSOCIATION; PROGRESSION; MELLITUS; SUSCEPTIBILITY; POPULATION; METABOLISM;
D O I
10.1155/2017/3560920
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy (DN) is one of the major chronic complications of diabetes. Genetic polymorphism of Apolipoprotein E (ApoE) has been proposed to participating in DN. The purpose of the study was to evaluate the relationship between ApoE genetic polymorphism and the presence of DN in Chinese type 2 diabetic patients. We studied 845 diabetic patients who were divided into DN group (n = 429) and control group (n = 416). ApoE genotype was determined by ApoE genotyping chip and the plasmatic biochemical characterization was performed on all subjects. There were differences (P < 0.001) in HbA1c, creatinine, and urinary albumin between the two groups. The ApoE epsilon 2 allelic frequency was 7.69% in DN group versus 3.49% in control group (OR = 2.22, 95% CI = 1.41-3.47, and P < 0.05), as expected, ApoE E2/E2 and E2/E3 genotype frequency were higher in DN group (13.75% versus 6.49%, P < 0.05). The ApoE epsilon 4 allelic frequency was 7.93% in DN group versus 11.54% in control group (OR = 0.70, 95% CI = 0.50-0.97, and P < 0.05), and DN group presented a lower frequency of ApoE E3/E4 and E4/E4 genotype frequency (14.91% versus 19.96% P < 0.05). These results suggest ApoE epsilon 2 allele may be a risk factor; however ApoE epsilon 4 allele may play a protective role of DN in Chinese type 2 diabetic patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Progression of diabetic nephropathy in type 1 diabetic patients
    Najafian, Behzad
    Mauer, Michael
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 1 - 8
  • [42] Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
    Lee, Mi Young
    Shim, Myoung Sook
    Kim, Bo Hwan
    Hong, Soon Won
    Choi, Ran
    Lee, Eun Young
    Nam, Soo Min
    Kim, Gun Woo
    Shin, Jang Yel
    Shin, Young Goo
    Chung, Choon Hee
    DIABETES & METABOLISM JOURNAL, 2011, 35 (02) : 130 - 137
  • [43] APOLIPOPROTEIN(A) IN INSULIN-DEPENDENT DIABETIC-PATIENTS WITH AND WITHOUT DIABETIC NEPHROPATHY
    GALL, MA
    ROSSING, P
    HOMMEL, E
    VOLDSGAARD, AI
    ANDERSEN, P
    NIELSEN, FS
    DYERBERG, J
    PARVING, HH
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1992, 52 (06): : 513 - 521
  • [44] Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients
    Werle, E
    Fiehn, W
    Hasslacher, C
    DIABETES CARE, 1998, 21 (06) : 994 - 998
  • [45] Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy
    Shelbaya, Salah
    Abu Shady, Manal Mohamed
    Nasr, Merhan Samy
    Bekhet, Meram Mohamed
    Abd-Al Mageed, Yasmine
    Abbas, Magdy
    CURRENT DIABETES REVIEWS, 2018, 14 (05) : 481 - 486
  • [46] Apolipoprotein E Gene Polymorphism, Glycated Hemoglobin, and Peripheral Arterial Disease Risk in Chinese Type 2 Diabetic Patients
    Hu, Yujing
    Ling, Tinghuan
    Yu, Min
    Bai, Yang
    Feng, Tongbao
    Zhang, Ping
    Wang, Yan
    DISEASE MARKERS, 2020, 2020
  • [47] Zinc Status in Type 2 Diabetic Patients: Relation to the Progression of Diabetic Nephropathy
    Al-Timimi, Dhia J.
    Sulieman, Dhia M.
    Hussen, Kajeen R.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (11)
  • [48] An implication of hypertriglyceridemia in the progression of diabetic nephropathy in Korean type 2 diabetic patients
    Kim, DM
    Kim, CS
    Nam, JY
    Park, JS
    Ahn, CW
    Cha, BS
    Kim, SK
    Kim, KR
    Lee, HC
    Huh, KB
    DIABETES, 2004, 53 : A503 - A503
  • [49] Morbidity in relation to stage of diabetic nephropathy in type-2 diabetic patients
    Alebiosu, CO
    Odusan, O
    Jaiyesimi, A
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2003, 95 (11) : 1042 - 1047
  • [50] Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy
    Christensen, PK
    Rossing, P
    Nielsen, FS
    Parving, HH
    DIABETIC MEDICINE, 1999, 16 (05) : 388 - 394